Admission Date:  [**2182-1-22**]              Discharge Date:   [**2182-1-25**]

Date of Birth:  [**2124-9-29**]             Sex:   F

Service: MEDICINE

Allergies:
Cephalosporins / Vancomycin / Quinolones / Sulfa (Sulfonamides)
/ Latex / Adhesive Tape / Vantin / Cefpodoxime

Attending:[**First Name3 (LF) 492**]
Chief Complaint:
Inability to decannulate trach


Major Surgical or Invasive Procedure:
[**2182-1-23**] Bronchoscopy
[**2182-1-24**] Rigid Bronchoscopy with Y-stent placement, trach tube
replacement
[**2182-1-25**] Bronchoscopy, Tracheostomy tube changed to #7 cuffed

History of Present Illness:
Ms. [**Known lastname 78098**] presents for evaluation of tracheobronchomalacia and
possible decannulation of tracheostomy tube.


Past Medical History:
s/p trach (7 years ago, failed to extubate p hip surgery), COPD,
DJD, MRSA PNA ([**10-11**]), Vtach ([**7-/2174**]), s/p multiple hip surgeries,
GERD, DMII, atrial stenosis, +Ab for transfusions


Social History:
Married lives with family
Tobacco: 30 pack-year quit [**2174**]

Family History:
non-contributory

Physical Exam:
97.1, HR 107, BP 107/60, RR17, 02 100% with trach mask
General: 57 year-old female trached in no apparent distress
HEENT; normocephalic
Neck: trach in place site clean dry intact, no erythema or
discharge
Card: A-fib/A-flutter
Resp: breathing comforbably with trach
GI: obese, bowel sounds positive, abdomen soft NT/ND
Extr - severe edema BLE, R leg open wound w/d dressing s/p
hematoma evacuation
Incision: RLE
Neuro: non-focal

Pertinent Results:
On [**2182-1-23**] pt underwent a flexible bronchoscopy showing thick
secretions in all airways (bloody in RUL), severe TBM in R and L
MS bronchi as well as a focal area of increased malacia in
mid-trachea

Brief Hospital Course:
Pt was admitted to interventional pulmonology on [**2182-1-22**] for
inability to decannulate her tracheostomy as well as evaluation
of tracheo bronchomalacia. On arrival pt was admitted to the ICU
and noted to have shortness of breath and orthopnea. Pt had been
started on prednisone and was switched to Solu-Medrol on
admission. Ceftazidime and clindamycin were also started upon
admission for pneumonia. On [**2182-1-23**] pt underwent a flexible
bronchoscopy showing thick secretions in all airways (bloody in
RUL), severe TBM in R and L MS bronchi as well as a focal area
of increased malacia in mid-trachea. Pt tolerated the procedure
well and was transferred to the surgical floor later that day.
On [**2182-1-24**] pt underwent flexible and rigid bronchoscopy with
Y-stent placement and trach stent as well as tracheostomy tube
replacement. Pt was transferred to the ICU on [**1-24**] for increased
PCO2 on ABG for which she was placed on BiPAP. On [**2182-1-25**] pt was
doing well, she once again underwent a flexible bronchoscopy
with exchange of tracheostomy tube to #7 cuffed tube. Pt was
transferred to [**Hospital2 **] [**Hospital3 6783**] hospital on [**2182-1-25**]

Medications on Admission:
Meds at Home: OxyContin 30", Protonix 40', Duragesic 100mcg
q72h,
Lasix 60', Coumadin 2', Robaxin 500' x 10d, glimepiride 4",
Duoneb q6, KLor 20", Klonopin 1', Percocet prn, Combivent prn,
Mylanta prn, albuterol prn, Proventil prn, ferrous sulfate 325',
Cardizem 360'
Meds on Transfer: Compazine prn, Lopressor 50", prednisone 20",
Lovenox 130", Lasix 60', Neurontin 300", Ativan prn, OxyContin
30", ferrous sulfate 325', Cardizem 360', clonazepam 1', Xopenex
prn, Atrovent prn, NG 0.4 prn, Lantus 20U qhs, clinda 600'''
([**1-18**]), ceftaz 1''' ([**1-18**]), prochlorperazine prn, ISS, Duragesic
100mcg q72h, Protonix 40', KLor 20"


Discharge Medications:
1. PredniSONE 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).

2. Gabapentin 300 mg Capsule Sig: One (1) Capsule PO BID (2
times a day).
3. Lorazepam 0.5 mg Tablet Sig: One (1) Tablet PO Q4H (every 4
hours) as needed.
4. Oxycodone 30 mg Tablet Sustained Release 12 hr Sig: One (1)
Tablet Sustained Release 12 hr PO every twelve (12) hours.
5. Ferrous Sulfate 325 mg (65 mg Iron) Tablet Sig: One (1)
Tablet PO DAILY (Daily).
6. Diltiazem HCl 360 mg Capsule, Sust. Release 24 hr Sig: One
(1) Capsule, Sust. Release 24 hr PO DAILY (Daily).
7. Clonazepam 1 mg Tablet Sig: One (1) Tablet PO QHS (once a day
(at bedtime)) as needed.
8. Guaifenesin 1,200 mg Tablet Sustained Release 12 hr Sig: One
(1) Tablet Sustained Release 12 hr PO BID (2 times a day).
9. Nitroglycerin 0.4 mg Tablet, Sublingual Sig: One (1) Tablet,
Sublingual Sublingual PRN (as needed).
10. Ipratropium Bromide 0.02 % Solution Sig: 0.2 MG/ML
Inhalation Q6H (every 6 hours).
11. Benzonatate 100 mg Capsule Sig: One (1) Capsule PO TID (3
times a day).
12. Fentanyl 100 mcg/hr Patch 72 hr Sig: One (1) Patch 72 hr
Transdermal Q72H (every 72 hours).
13. Pantoprazole 40 mg Tablet, Delayed Release (E.C.) Sig: One
(1) Tablet, Delayed Release (E.C.) PO Q24H (every 24 hours).
14. Albuterol Sulfate 2.5 mg/3 mL Solution for Nebulization Sig:
2.5mg/3ml MG/ML Inhalation Q2H (every 2 hours) as needed.
15. Metoprolol Tartrate 50 mg Tablet Sig: One (1) Tablet PO BID
(2 times a day).
16. Acetylcysteine 20 % (200 mg/mL) Solution Sig: 1-2 MLs
Miscellaneous Q6H (every 6 hours).
17. Enoxaparin 150 mg/mL Syringe Sig: One (1)  Subcutaneous Q12H
(every 12 hours).
18. Guaifenesin 600 mg Tablet Sustained Release Sig: Two (2)
Tablet Sustained Release PO BID (2 times a day).
19. Insulin
RISS
20. Clindamycin Phosphate 600 mg/4 mL Solution Sig: One (1)
Intravenous every eight (8) hours.
21. Ceftazidime 1 gram Recon Soln Sig: One (1) Recon Soln
Intravenous Q8H (every 8 hours).


Discharge Disposition:
Extended Care

Facility:
[**First Name8 (NamePattern2) 1495**] [**Hospital3 6783**] Hospital

Discharge Diagnosis:
Trachaelbronchomalacia s/p Y stent [**1-11**]
Trach (7 years ago, failed to extubate p hip surgery), COPD,
DJD, MRSA PNA ([**10-11**]), Vtach ([**7-/2174**]), Atrial Stenosis, Diabetes
Mellitus T2
GERDs, A. Flutter s/p cardioversion, Pulmonary Embolism
s/p multiple hip surgeries
Right leg hematoma evacuation [**12-11**]
+Ab for transfusions


Discharge Condition:
Stable, deconditioned


Discharge Instructions:
Call Dr.[**Name (NI) 5070**] office [**Telephone/Fax (1) 7769**] if experience:
-Fever > 101 or chills
-Increased cough, shortness of breath, or sputum production
-Chest pain
Continue Guaifenesin 1200mg twice daily while stent in place.


Followup Instructions:
Follow-up with Dr.[**Name (NI) 5070**] office in 4 weeks [**Telephone/Fax (1) 7769**]
Follow-up with your PCP


                             [**First Name8 (NamePattern2) **] [**Name8 (MD) **] MD [**Doctor First Name 494**]

